Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for SKIN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -1.205M
March 31, 2026 -1.649M
December 31, 2025 -1.382M
September 30, 2025 -1.084M
June 30, 2025 -1.552M
March 31, 2025 -1.145M
December 31, 2024 -0.862M
September 30, 2024 -2.092M
June 30, 2024 -2.038M
March 31, 2024 -1.802M
December 31, 2023 -2.168M
September 30, 2023 -4.436M
Date Value
June 30, 2023 -3.219M
March 31, 2023 -21.68M
December 31, 2022 -2.824M
September 30, 2022 -7.741M
June 30, 2022 -4.879M
March 31, 2022 -3.425M
December 31, 2021 349.10M
September 30, 2021 -20.08M
June 30, 2021 -8.131M
March 31, 2021 -0.988M
December 31, 2020 -1.12M
September 30, 2020 -1.272M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. 0.00
CCA Industries, Inc. -0.0039M
Cyanotech Corp. -0.059M
The Estée Lauder Companies, Inc. -185.00M
Edgewell Personal Care Co. -14.10M